Friday, November 27, 2015

Entrepreneurs Touched the Stars at the Copenhagen InvestHorizon Early Stage Camp

On Monday and Tuesday 16-17 November, EBAN Winter University 2015 hosted in the Copenhagen Business School, one of Europe’s leading institutions for business and entrepreneurship and the KADK, Copenhagen's Royal Academy of Arts around 200 entrepreneurs and angel investors for the InvestHorizon Early Stage Camp and Global Investor Forum

Focused on the theme of science, innovation and the creative industries, this unique edition of the Early Stage Camp saw the participation of 20 extremely promising entrepreneurs from all over Europe with projects and new technologies that will for sure radically change the world we live in.

The first day started off with a warm cup of coffee and investor readiness coaching led by 8 top level mentors:
  • Ari Korhonen, EBAN Vice President, serial entrepreneur and angel investor in 28 different startups.
  • Ivar Siimar, President of Estonia Business Angel Network, serial entrepreneur and angel investor 
  • Paolo Borella (a.k.a Master Control), Director of Appcampus’s Accelerator in Finland 
  • Jan Rosenbom, Equity partner in Danish matchmaking consultancy group Keystones and angel investor. 
  • Bruno Cotta, Director of the Enterprise Lab at Imperial College London and Visiting Fellow at the Business School 
  • Heidi Kakko, Former Director Estonian Venture Capital Fund
  • Juan Roure, Professor of Entrepreneurship at IESE Business School and Visiting Professor at the Graduate School of Business at Stanford, INSEAD, Harvard Business School and at CEIBS (China). 
  • Candace Johnson (a.k.a The Satellady), President of EBAN, serial entrepreneur, angel investor and co-initiator of Europe’s largest satellite company - SES Astra

The Early Stage Camp was also characterized by a new model of coaching, with individual training and mentoring for each startup. In this intimate setting, the entrepreneurs received one on one advice from the coaches on how to fine tune their pitch and make it as impactful as possible for the investors listening. On the second day, the entrepreneurs had the opportunity to pitch before an even larger audience of 500 Angel Investors, Venture Capitalists, and Early Stage Market Players from around the world and to mingle and network with them before and after their pitches. For sure a model that will be repeated in the editions to come!

After the networking lunch on the first day, the stage was set for the moment everyone was waiting for: The Global Investor Forum. 23 startups took turns at presenting to a panel of over 30 professional investors and an audience of 200 people. A complete list of the startups, judges and investors can be found here:

- Braingene
- Glarify
- Elysium
- GloW
- Reverse Resources
- Travel is a Lifestyle
- Yottabite
- BeeZon
- Guide Me Right
- Sherlock s.r.l.
- FTBATCH - Optics11 BV
- Gfnork
- Owl Tech
- Scoo mobility gmbh
- Silversky3D VRT Ltd - VECID
- StemCell2MAX
- Theralight
- Garden of Ideas

The Global Investor Forum became a celebration of research and development findings from Europe’s leading organizations. Thanks to the participation of 10 Proof of Concept Grantees coming from the European Research Council and 4 European Space Agency sponsored entrepreneurs, sophisticated technologies took center stage setting the bar high for future editions of the Forum.

After all startups had their chance to pitch and the votes assigned by the jury, InvestHorizon specially recognized two startups for their achievements with dedicated awards:

The Global Investment Forum’s “Most Investable Company” award goes to:
StemCell2Max is a biotechnology startup in the field of regenerative medicine with proven market acceptance and internationally recognized innovating discovery (patented and published in Nature), plus a growing track-record in sales. StemCell2Max developed a new technology for blood stem cell expansion for researchers and for developing treatments for cancer. Although the award was independently and quantitatively determined, EBAN is proud that a group of Portugese Business Angels - Busy Angels Venture Capital Investors - first invested in StemCell2Max and that the startup was also an ERC Proof of Concept Grantee, all the while having its CEO Maria Brandão de Vasconcelos, MBA, and CMO Filipa Matos Baptista, PhD, as co-founders of this exciting, innovative, and most investable company.

The Global Investment Forum’s “One to Watch” award goes to:
CopyMe3D is a TU Munich spin-off company focused on state-of-the-art technology for 3D scanning. It was founded at the Chair for Computer Vision, one of the world’s leading computer vision research labs. Products include person scanners which automatically create accurate colored 3D models of people that can be printed on 3D color printers. This high-tech startup develops products for the consumer market and for the medical domain (orthopedics and plastic surgery). CopyMe3D is also licensing technology to reconstruct large-scale outdoor environments from moving cameras in real-time which can be deployed for driver assistance and self-driving cars. This venture received funding from the ERC Proof of Concept grantee scheme and is led by Prof. Daniel Cremers of the Technical University Munich (TUM).

On the evening of the first day of the Early Stage Camp, the entrepreneurs and Angel Investors were invited by the southern Swedish Regional Council for a get-together with Swedish entrepreneurs.

The second day of the Early Stage Camp at Copenhagen's venerable Royal Academy of the Arts gave all of the entrepreneurs who stayed a chance to hear world-class speakers on innovation, entrepreneurship, and early-stage investment as well as to attend workshops. Pitches were interspersed throughout the entire program and brought real relevance to the speeches - combining theory with practice for both entrepreneurs and investors. That night, the Early Stage Camp entrepreneurs joined together with the EBAN Winter University and Creative Cup entrepreneurs from 60 countries around the world for a networking gathering.